Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

NCT04227106 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abeona Therapeutics, Inc